Literature DB >> 8135567

Survival from acute non-lymphocytic leukaemia, 1971-88: a population based study.

C A Stiller1, E M Eatock.   

Abstract

Survival rates were studied among 1258 children with acute non-lymphocytic leukaemia diagnosed in 1971-88 and included in the population based National Registry of Childhood Tumours. Of the total, 147 (12%) died without receiving treatment. Among the remaining treated children, actuarial five year survival rates were 6% in 1971-4, 15% in 1975-9, 23% in 1980-3, and 40% in 1984-8. Infants aged less than 1 year had a significantly worse prognosis and there was a significant trend towards lower survival rates with increasing white cell count. No independent significant effects on survival were found with sex, French-American-British (FAB) subtype, or the presence or absence of Down's syndrome. Children entered in national trials had a higher survival rate than those who were not entered, and children treated at teaching hospitals had a higher survival rate than those who were treated elsewhere. Among the 535 (43%) children who survived at least one year from diagnosis no factor studied had a significant effect on survival, emphasising the importance of achieving first remission as a determinant of long term survival.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8135567      PMCID: PMC1029747          DOI: 10.1136/adc.70.3.219

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  16 in total

1.  Acute nonlymphocytic leukemias of childhood. Inter-observer variability and problems in the use of the FAB classification.

Authors:  J C Argyle; D R Benjamin; B Lampkin; D Hammond
Journal:  Cancer       Date:  1989-01-15       Impact factor: 6.860

2.  Intensive induction and consolidation chemotherapy for adults and children with acute myeloid leukaemia (AML) joint AML trial 1982-1985.

Authors:  R E Marcus; D Catovsky; H G Prentice; A C Newland; J M Chessells; R F Stevens; I M Hann; J M Goldman; A V Hoffbrand; D A Galton
Journal:  Haematol Blood Transfus       Date:  1987

3.  Improvement in outcome for children with acute nonlymphocytic leukemia. A report from the Childrens Cancer Study Group.

Authors:  J D Buckley; R L Chard; R L Baehner; M E Nesbit; B C Lampkin; W G Woods; G D Hammond
Journal:  Cancer       Date:  1989-04-15       Impact factor: 6.860

4.  Centralisation of treatment and survival rates for cancer.

Authors:  C A Stiller
Journal:  Arch Dis Child       Date:  1988-01       Impact factor: 3.791

5.  Acute myeloid leukaemia in childhood: treatment in the United Kingdom.

Authors:  J M Chessells; C A Sieff; A Rankin
Journal:  Haematol Blood Transfus       Date:  1983

6.  Treatment centre size, entry to trials, and survival in acute lymphoblastic leukaemia.

Authors:  C A Stiller; G J Draper
Journal:  Arch Dis Child       Date:  1989-05       Impact factor: 3.791

7.  Monocytic leukemia in infancy. A review of eight children.

Authors:  P J Darbyshire; J H Smith; A Oakhill; M G Mott
Journal:  Cancer       Date:  1985-10-01       Impact factor: 6.860

8.  Acute myeloid leukaemia in childhood: clinical features and prognosis.

Authors:  J M Chessells; U O'Callaghan; R M Hardisty
Journal:  Br J Haematol       Date:  1986-07       Impact factor: 6.998

9.  Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group.

Authors:  J M Bennett; D Catovsky; M T Daniel; G Flandrin; D A Galton; H R Gralnick; C Sultan
Journal:  Br J Haematol       Date:  1976-08       Impact factor: 6.998

10.  Principal results of the Medical Research Council's 8th acute myeloid leukaemia trial.

Authors:  J K Rees; R G Gray; D Swirsky; F G Hayhoe
Journal:  Lancet       Date:  1986-11-29       Impact factor: 79.321

View more
  17 in total

1.  Time trends and prognostic factors for survival from childhood cancer: a report from the Childhood Cancer Registry of Piedmont (Italy).

Authors:  Elisa Dama; Guido Pastore; Maria Luisa Mosso; Milena Maria Maule; Luisa Zuccolo; Corrado Magnani; Franco Merletti
Journal:  Eur J Pediatr       Date:  2006-01-13       Impact factor: 3.183

2.  Central nervous system tumours lack national studies.

Authors:  R Thorne; N K Foreman
Journal:  Arch Dis Child       Date:  1994-07       Impact factor: 3.791

3.  Association of clinical trial enrollment and survival using contemporary therapy for pediatric acute lymphoblastic leukemia.

Authors:  Diana J Moke; Matthew J Oberley; Deepa Bhojwani; Chintan Parekh; Etan Orgel
Journal:  Pediatr Blood Cancer       Date:  2017-09-06       Impact factor: 3.167

Review 4.  Global characteristics of childhood acute promyelocytic leukemia.

Authors:  L Zhang; A Samad; M S Pombo-de-Oliveira; G Scelo; M T Smith; J Feusner; J L Wiemels; C Metayer
Journal:  Blood Rev       Date:  2014-09-30       Impact factor: 8.250

5.  Improved outcome of acute myeloid leukaemia in Down's syndrome.

Authors:  J L Craze; G Harrison; K Wheatley; I M Hann; J M Chessells
Journal:  Arch Dis Child       Date:  1999-07       Impact factor: 3.791

6.  Comprehensively evaluating cancer survival in children with birth defects: a population-based assessment.

Authors:  Amanda E Janitz; Jeremy M Schraw; Chao Xu; Philip J Lupo
Journal:  Cancer Causes Control       Date:  2022-01-11       Impact factor: 2.506

7.  Population based survival rates for childhood cancer in Britain, 1980-91.

Authors:  C A Stiller
Journal:  BMJ       Date:  1994-12-17

8.  Comparison of survival outcomes among cancer patients treated in and out of clinical trials.

Authors:  Joseph M Unger; William E Barlow; Diane P Martin; Scott D Ramsey; Michael Leblanc; Ruth Etzioni; Dawn L Hershman
Journal:  J Natl Cancer Inst       Date:  2014-03-13       Impact factor: 13.506

Review 9.  Outcomes of patients who participate in randomized controlled trials compared to similar patients receiving similar interventions who do not participate.

Authors:  Gunn Elisabeth Vist; Dianne Bryant; Lyndsay Somerville; Trevor Birminghem; Andrew D Oxman
Journal:  Cochrane Database Syst Rev       Date:  2008-07-16

10.  Survival from adult leukaemia in England and Wales up to 2001.

Authors:  B Rachet; E Mitry; A Shah; N Cooper; M P Coleman
Journal:  Br J Cancer       Date:  2008-09-23       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.